Last updated on: 24/10/2016
1. Contact details
This data source is maintained by the following centre registered in the ENCePP inventory of research centres: MFIR-Ulster
Name of data sourceEUROCAT
Name under which the data source should be displayed in the inventory (e.g short name if one exists)EUROCAT
Name of organisation
1) Department/research groupJRC/EUROCAT
2) Organisation/affiliationJoint Research Centre (JRC)
Administrative Contact
Title Dr
Last name Kinsner-Ovaskainen
First name Agnieszka
Address line 1Via Fermi 2749
Address line 2TP 127
Address line 3E.C. Joint Research Centre
CityIspra
Postcode21027
CountryItaly
Scientific Contact
Title Professor
Last name Morris
First name Joan
Address line 1Wolfson Institute of Preventive Medicine
Address line 2Queen Mary University of London
Address line 3Charterhouse Square
CityLondon
PostcodeEC1M 6BQ
CountryUnited Kingdom
2. Description/category
Disease/case registry
Exposure registry
3.1 Coverage of licensed medicinal products
Licensed Medicinal Product
Comments
OTC
Vaccines
Prescribed medications taken by mother prior to and during pregnancy
3.2 ATC code (5th level)
Yes
3.3 Other product dictionaries
No
3.4 Recording of indication for use
Yes
Is a coding dictionary being used? WHO ICD classification
4. Coverage of events
Event
Dictionary
Dictionary details
Adverse events (for pharmacovigilance databases)
Yes
Prior to or during pregnancy WHO ICD classification
Diagnosis in primary care
Yes
WHO ICD classification
Specialist diagnosis
Yes
WHO ICD classification
Discharge diagnosis
Yes
WHO ICD classification
Overdoses
Yes
WHO ICD classification
Teratogenic events
Yes
WHO ICD classification
5. Year of establishment
1980
6. Geographical origin of data
EEA/EFTA countries
Austria
Belgium
Croatia
Czech Republic
Denmark
Finland
France
Germany
Hungary
Ireland
Italy
Malta
Netherlands
Norway
Poland
Portugal
Spain
Sweden
Switzerland
United Kingdom
Non EEA/EFTA areas
Non EEA Europe (excluding Russia & former Soviet Republics)
7. Demographical extent of data collection
Regional sub-set :
Some countries have a national registry which cover the entire country; others are resticted to a specific population region within the country
8. Age groups
17 years and under [Paediatrics]
preterm newborn infants
term newborn infants (0 to 27 days)
infants and toddlers (28 days to 23 months)
children (2 to 11 years)
9. Size of the source/catchment population
28,913,133
10 a. Total (cumulative) number of persons with actual data
746,664
10 b. Number of persons with active data collection in past calendar year
15,505
11. Possibility to obtain additional information on the patient
a) Clinical information from treating physician?
No
b) Questionnaire data from the patient?
No
c) Genetic information or samples?
No
12. Possibility of links to other sources of data
No
13. Written policy governing data access
Yes
14. Committee to evaluate requests for data access
Yes
15. Charge/fee for data access
No
16. Selected publications of the last 5 calendar years using data from this data source
ReferenceLink to web-publication
Loane M, Dolk H, Garne E, Greenlees R and a EUROCAT Working Group (2011). Paper 3: EUROCAT Data Quality Indicators for population-based registries of congenital anomalies. Birth Defects Research Part A Clin Mol Teratol, 91: S23-S30
Boyd PA, Hauesler M, Barisic I, Loane M, Garne E, Dolk H (2011). The EUROCAT Network: Organisation and Processes. Birth Defects Res Part A Clin Mol Teratol Suppl 91:S2-S15
Dolk H, Loane MA, Garne E, and a EUROCAT Working Group (2011). Congenital Heart Defects in Europe: prevalence and perinatal mortality 2000-2005. Circulation 123: 841-849
Jentink J, Dolk H, Loane MA, Morris JK, Wellesley DG, Garne E, and de Jong-van den Berg LTW (2010). Intrauterine carbamazepine exposure and specific congenital malformations. BMJ; 341: c6581
Khoshnood B, Greenlees R, Loane M, Dolk H and a EUROCAT working group (2011). EUROCAT Public Health Indicators for congenital anomalies in Europe. Birth Defects Res Part A Clin Mol Teratol Suppl 91: S16-S22
